Advertisement
Original Research|Articles in Press, 100897

FETAL SEX AND THE DEVELOPMENT OF GESTATIONAL DIABETES MELLITUS IN POLYCYSTIC OVARIAN SYNDROME GRAVIDAE

Published:February 06, 2023DOI:https://doi.org/10.1016/j.ajogmf.2023.100897

      Abstract

      Background

      Polycystic ovarian syndrome is characterized by elevated androgens and is a well-known risk factor for the occurrence of gestational diabetes mellitus. Androgens (particularly dehydroepiandrosterone-sulfate) are crucial for the development and characteristics of the male reproductive tract during fetal life, and fetal dehydroepiandrosterone-sulfate enters the placenta where it is metabolized and functions as an estrogen substrate. Given this unique sex-specific relationship in androgens and the association of serum dehydroepiandrosterone-sulfate with insulin resistance, we hypothesized that metabolic comorbidities in pregnancy might differ by fetal sex in gravidae with polycystic ovarian syndrome, notably those with infertility.

      Objective

      Our objective was to employ a large population-based database to explore if fetal sex was significantly associated with gestational diabetes mellitus in infertile gravidae with polycystic ovarian syndrome, after controlling for confounders.

      Study Design

      This study was designed to evaluate the risk of occurrence and rates of gestational diabetes mellitus among infertile gravidae with a history of polycystic ovarian syndrome. We used a 2-hospital, single academic institution database comprised of over 30,000 subjects enrolled from September 2011 to June 2021 to identify all gravidae with diagnoses of infertility and polycystic ovarian syndrome at time of delivery and compare them with gravidae that lacked these co-morbidities. Data on covariates, including but not limited to maternal age, body mass index, fetal sex, race, ethnicity, presence or absence of hypertensive disease, and presence or absence of gestational diabetes were identified. Unadjusted and adjusted odds rations were calculated.

      Results

      We found a statistically significant association between fetal female sex and the development of gestational diabetes mellitus in gravidae with polycystic ovarian syndrome [odds ratio for female versus male 2.13 (95% confidence interval, 1.06-4.32), p =0.03]. After adjusting for potential confounders identified in our univariate analyses, there continued to be a statistically significant association between female fetuses and the development of gestational diabetes mellitus [adjusted odds ratio for female versus male 2.10 (95% confidence interval 1.04-4.41), p =0.04]. In contrast, there was no significant association between fetal sex and the development of gestational diabetes mellitus in our similar analysis of gravidae without infertility and polycystic ovarian syndrome (p=0.99).

      Conclusion

      While gestational diabetes mellitus is of multifactorial origin, we found that fetal female sex is associated with gestational diabetes mellitus in infertile gravidae with polycystic ovarian syndrome but not their comparative controls. Further research on the molecular mechanisms driving the association between female fetuses and development of gestational diabetes mellitus in the context of maternal polycystic ovarian syndrome is warranted.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Obstetrics & Gynecology MFM
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect